Sex and gender differences in autoimmune diseases
G Zandman-Goddard, E Peeva, Z Rozman… - Sex and gender aspects …, 2011 - Springer
Autoimmune and rheumatological diseases often come to mind when thinking about gender
differences in medicine. While sex ratios vary among the conditions presented herein …
differences in medicine. While sex ratios vary among the conditions presented herein …
Microvascular heart involvement in systemic autoimmune diseases: The purinergic pathway and therapeutic insights from the biology of the diseases
E De Lorenzis, E Gremese, S Bosello… - Autoimmunity …, 2019 - Elsevier
Heart involvement–often asymptomatic–is largely underestimated in patients with systemic
autoimmune diseases (SADs). Cardiovascular events are more frequent in patients with …
autoimmune diseases (SADs). Cardiovascular events are more frequent in patients with …
[图书][B] Reversibility of Chronic Disease and Hypersensitivity, Volume 5: Treatment Options of Chemical Sensitivity
WJ Rea, KD Patel - 2017 - taylorfrancis.com
The clinical approaches to the chronic degenerative diseases that drain our resources, and
compromise our well-being, have become almost exclusively symptom-focused. The …
compromise our well-being, have become almost exclusively symptom-focused. The …
Treatment patterns and control of hypertension in systemic lupus erythematosus (SLE): a cross-sectional study
JL Liu, CA Pineau, LP Grenier, E Vinet, F Kalache… - BMJ open, 2021 - bmjopen.bmj.com
Objective Hypertension (HTN) is common in systemic lupus erythematosus (SLE),
representing a key risk factor for cardiovascular and renal disease. We described HTN …
representing a key risk factor for cardiovascular and renal disease. We described HTN …
Investigation of the association between carotid artery intima-media thickness (IMT) and cardiac risk factors in patients with systemic lupus erythematosus
Background: The relationship between SLE and traditional risk factors for cardiovascular
events was evaluated. Methods: The data regarding sixty patients with SLE and 30 healthy …
events was evaluated. Methods: The data regarding sixty patients with SLE and 30 healthy …
[HTML][HTML] 狼疮性肾炎合并射血分数减低心力衰竭患者的临床特征及预后分析
汤文君, 李喆, 许书添, 周玉超, 王杨, 娄丽璇… - 肾脏病与透析肾移植 …, 2022 - njcndt.com
目的: 探讨狼疮性肾炎(LN) 合并射血分数减低心力衰竭(HFrEF) 患者的临床特征及预后. 方法:
本研究纳入2013 年1 月至2022 年2 月国家肾脏疾病临床医学研究中心重症监护病房(ICU) …
本研究纳入2013 年1 月至2022 年2 月国家肾脏疾病临床医学研究中心重症监护病房(ICU) …
[PDF][PDF] Systemic lupus erythematosus: managing cardiovascular risk factors
A Rahman - The Lancet Rheumatology, 2024 - hub.uoa.gr
Cardiovascular disease is one of the major comorbidities and most important causes of
death in patients with systemic lupus erythematosus (SLE). Young women with SLE are 50 …
death in patients with systemic lupus erythematosus (SLE). Young women with SLE are 50 …
[HTML][HTML] Cardiovascular events in patients with systemic lupus erythematosus
A Smržová, P Horák, M Skácelová, M Žurek… - Cor et Vasa, 2014 - Elsevier
Introduction Cardiovascular involvement represents the leading cause of mortality in SLE
patients. Its most common manifestations include pericarditis, valvular affections, conduction …
patients. Its most common manifestations include pericarditis, valvular affections, conduction …